Skip NavigationSkip to Content

Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles

  1. Author:
    Altunbas, A.
    Lee, S. J.
    Rajasekaran, S. A.
    Schneider, J. P.
    Pochan, D. J.
  2. Author Address

    [Altunbas, A; Pochan, DJ] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA [Altunbas, A; Pochan, DJ] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA [Lee, SJ; Rajasekaran, SA] Alfred I DuPont Hosp Children, Nemours Ctr Childhood Canc Res, Canc Epigenet Lab, Wilmington, DE 19803 USA [Schneider, JP] NCI, Biol Chem Lab, Ctr Canc Res, Frederick, MD 21702 USA;Pochan, DJ (reprint author), Univ Delaware, Dept Mat Sci & Engn, 201 DuPont Hall, Newark, DE 19716 USA;pochan@udel.edu
    1. Year: 2011
    2. Date: Sep
  1. Journal: Biomaterials
    1. 32
    2. 25
    3. Pages: 5906-5914
  2. Type of Article: Article
  3. ISSN: 0142-9612
  1. Abstract:

    Curcumin, a hydrophobic polyphenol, is an extract of turmeric root with antioxidant, anti-inflammatory and anti-tumorigenic properties. Its lack of water solubility and relatively low bioavailability set major limitations for its therapeutic use. In this study, a self-assembling peptide hydrogel is demonstrated to be an effective vehicle for the localized delivery of curcumin over sustained periods of time. The curcumin-hydrogel is prepared in-situ where curcumin encapsulation within the hydrogel network is accomplished concurrently with peptide self-assembly. Physical and in vitro biological studies were used to demonstrate the effectiveness of curcumin-loaded beta-hairpin hydrogels as injectable agents for localized curcumin delivery. Notably, theological characterization of the curcumin-loaded hydrogel before and after shear flow have indicated solid-like properties even at high curcumin payloads. In vitro experiments with a medulloblastoma cell line confirm that the encapsulation of the curcumin within the hydrogel does not have an adverse effect on its bioactivity. Most importantly, the rate of curcumin release and its consequent therapeutic efficacy can be conveniently modulated as a function of the concentration of the MAX8 peptide. (C) 2011 Elsevier Ltd. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.biomaterials.2011.04.069
  2. WOS: 000292714700019

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel